These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6044990)

  • 1. The antigenic effect of measles vaccine in infants and young children.
    Henigst W; Müller F
    Ger Med Mon; 1967 Feb; 12(2):59-61. PubMed ID: 6044990
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and the study of live measles vaccine from highly attenuated strain Enders-Schwarz-Chumakov (ESC).
    Chumakov MP; Voroshilova MK; Grachev VP; Dzagurov SG; Sinyak KM
    Prog Immunobiol Stand; 1967; 3():194-5. PubMed ID: 5379939
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.
    Norrby E; Lagercrantz R; Gard S
    Acta Paediatr Scand; 1966 Jan; 55(1):73-8. PubMed ID: 5919475
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of the incidence of measles in Bratislava before and after introduction of vaccination (author's transl)].
    Ferencei M; Holanová J; Dimitrova E
    Bratisl Lek Listy; 1976 Jun; 65(6):659-71. PubMed ID: 974833
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serologic indices of measles immunity in children exposed to measles].
    Tikhonova NT; Khrometskaia TM; Ignat'eva GV; Gerasimova AG; Livanova LV
    Vopr Virusol; 1974; 19(0):357-63. PubMed ID: 4837951
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Status of immunity after measles vaccination (author's transl)].
    La Cauza C; Galluzzi F; Salti R
    Ann Sclavo; 1980; 22(4):545-54. PubMed ID: 7018418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of measles infection and measles vaccination on the immunological reactivity in the child].
    Askerov VF; Sadykhova AN
    Pediatriia; 1968 Jun; 7():34-9. PubMed ID: 5710299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 16. [New methods on the measles prophylaxis (author's transl)].
    de Blasi R; Fazio-Gentile G
    Ann Sclavo; 1979; 21(2):113-59. PubMed ID: 485597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serologic response to measles, rubella and parotitis vaccines].
    Ruíz-Gómez J; Alvarez y Muñoz MT; Jasso Gutiérrez L; Martínez Sánchez A
    Salud Publica Mex; 1977; 19(3):437-41. PubMed ID: 594841
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
    Stehr K; Enders G; Suschke HJ; Spiess H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine.
    McMurray DN; Loomis SA; Casazza LJ; Rey H
    Bull Pan Am Health Organ; 1979; 13(1):52-7. PubMed ID: 427297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.